Home - Boston Life Sciences Times

LATEST ARTICLES

Healthcare

Magnus Medical Enrolls First Patient at UMass Chan in DoD-Funded Pivotal Study of SAINT Therapy for Postpartum Depression

Life Sciences Times - February 5, 20260

Real Estate

Dash Bio Expands Massachusetts Operations With New 24,000-Square-Foot GLP Lab in Waltham

Life Sciences Times - February 4, 20260

Technology

HighRes and Opentrons Partner to Develop AI Agent-to-Agent Lab Automation Workflow

Life Sciences Times - February 4, 20260

Medtech

Hologic Secures FDA Approval for Aptima HPV Assay as Primary Cervical Cancer Screening Option

Life Sciences Times - February 4, 20260

People on the Move

ZOLL Medical Names Eric Knudsen as Chief Executive Officer

Life Sciences Times - February 4, 20260

Technology

Synthpop Raises $15 Million Series A to Expand AI Platform for Healthcare Workflow Automation

Life Sciences Times - February 4, 20260

Biotech

Affinia Therapeutics Receives FDA Clearance to Begin Clinical Trial of AFTX-201 for BAG3-Associated Dilated Cardiomyopathy

Life Sciences Times - February 4, 20260

Technology

UpToDate Solutions from Wolters Kluwer Earn Top KLAS Rankings for Patient Engagement and Education

Life Sciences Times - February 4, 20260

Venture Capital

Apeiron Labs Raises $9.5 Million Series A to Expand Ocean Intelligence Platform

Life Sciences Times - February 4, 20260

Biotech

Alloy Speeds Mediar’s Path to the Clinic for Complex Fibrosis Targets

Life Sciences Times - February 3, 20260

1...383940...831 Page 39 of 831

Radiology Partners Appoints Former Maryland Gov. Larry Hogan to Board

May 1, 2026

SK Capital Completes Sale of Noramco Group Businesses to Siegfried

May 1, 2026

GoodRx Expands Access to Oral Ozempic for Type 2 Diabetes Patients

May 1, 2026

Seaport Therapeutics Prices Upsized IPO at $18 Per Share

May 1, 2026

Most Popular

Radiology Partners Appoints Former Maryland Gov. Larry Hogan to Board

SK Capital Completes Sale of Noramco Group Businesses to Siegfried

GoodRx Expands Access to Oral Ozempic for Type 2 Diabetes Patients

Seaport Therapeutics Prices Upsized IPO at $18 Per Share

Recent Comments

EDITOR PICKS

Iterative Health Raises $77 Million to Expand Clinical Research Network

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

THIS WEEK'S STORIES

VGM and Trace Medical Expand Partnership With Exclusive Nationwide Agreement

Newron Reports FDA Hold on New Enrollment at U.S. Sites in Schizophrenia Study

Boston Cell Standards Advances Toward FDA Qualification for Cancer Testing Platform

POPULAR CATEGORY

ABOUT US

FOLLOW US